The life sciences industry has undergone seismic shifts in the three years, with sweeping changes across research, development, and commercialization. Industry trends point to a world with fewer barriers, faster drug development, and more efficient communication. Here are ten trends life science professionals need to know to stay ahead in 2023.
10 Changing Life Sciences Industry Trends
1. Focusing on Health Equity:
Equality and access to healthcare are becoming increasingly essential policy concerns. Companies are investing in projects that provide equitable health care, such as remote monitoring devices and telehealth technology, to reach populations who have not historically had good access to healthcare.
2. Big Data:
The shift from a fee-for-service reimbursement model to one based on value, data, and analytics will become even more critical. Big data has the potential to provide insights into medical trends and treatments that were not previously available, which can help improve outcomes for patients and reduce costs.
This shift towards value-based reimbursement models is creating a new emphasis on using analytics and other data-driven approaches to healthcare. As health systems increasingly rely on predictive models and algorithms to inform decisions, ensuring that these models are appropriately validated and produce reliable results will be critical. Additionally, this data can be used to create personalized treatments for patients that optimize outcomes while reducing costs.
3. Personalized Medicine:
With new technology comes an evolution in personalized medicine. Advances in genetics and genomics are enabling a shift towards a more personalized approach to healthcare, with treatments tailored to individuals. This is helping to improve outcomes for patients and reduce costs for providers.
4. Accelerating Digitization:
COVID-19 exacerbated the digital transformation in every healthcare industry, forcing sectors to adapt to the no-contact world. Think of the vast strides just in the past two years. A considerable increase in telehealth (remote healthcare visits, decentralized clinical studies, etc.) and advanced medical devices (wearables and sensors) is just a small part of modern medicine.
5. Rise of AI and ML:
Advances in artificial intelligence (AI) and machine learning (ML) are revolutionizing the life sciences industry. AI can quickly analyze sizeable amounts of data, enabling companies to develop drugs faster and cheaper.
6. Scaling Cloud Platforms and Securing Data:
Clinical trial managers increasingly rely on cloud-based platforms to store and manage data associated with clinical trials. As the amount of data being collected continues to increase, it is critical that clinical trial managers have access to secure and reliable cloud platforms that can effectively scale up as needed.
Additionally, they must be proactive in implementing stringent security protocols to protect patient data and ensure compliance with HIPAA and GDPR. By properly managing their cloud infrastructure, clinical trial managers can ensure data safety while ensuring operational efficiency.
7.. Shortening Vaccine Development Timeline:
The pandemic accelerated the development, testing, and distribution of drugs and vaccines more than ever. Official regulators like the FDA and EMA played a key role in our speedy progress over the last few years, and it won’t slow down.
Infrastructure has been developed over the years to keep pace and never slow down, and the trends show that these swift projects are going to be the norm going forward.
8. Increasing Reliance on Data Analytics
With an increasing number of clinical trials being conducted, the ability to quickly analyze large datasets is becoming more important to pharmaceutical companies. Data analytics tools are helping researchers understand the impact a potential therapy or drug has on a patient population much faster than ever before.
9. Adoption of Biomarkers
Biomarkers are becoming an increasingly important tool for evaluating patients in clinical trials, with researchers able to measure more precisely how a potential therapy or drug impacts an individual.
Clinical trial managers must be prepared to embrace the use of biomarkers in their clinical trials. Biomarkers provide valuable insights into disease processes, allowing for more precise diagnosis and treatment. By leveraging these types of molecular signatures, clinical trial managers can quickly and accurately detect changes in a patient’s condition, which could indicate response to treatment. Additionally, biomarkers can help clinicians stratify patients more precisely, providing more accurate information on who is most likely to respond favorably to specific treatments.
For clinical trial managers to effectively use biomarkers in their studies, they need the right infrastructure and data management solutions in place. Sufficient storage should be available so that all biomarker data can be collected and stored safely and securely. This data should also be structured so that it can easily be analyzed with AI or ML algorithms. By ensuring that their technology stack is equipped to handle the demands of a biomarker-based study, clinical trial managers can ensure that they are able to maximize the potential benefits of this powerful tool.
10. An Increase in Industry Mergers and Acquisitions
The healthcare industry has been trending towards more mergers and acquisitions for the past few years. “...the 10 largest biopharma M&A deals in 2022 totaled around $65 billion. While that was an increase from $53 billion in 2021, it was a notable downturn from prior years.”
Tens of billions of dollars are moved around each year for these massive companies to collaborate and create better medicine. With these large conglomerates in place, more medicine can be generated, more clinical trials will be conducted, and real medical breakthroughs can become possible.
From the rapid adoption of digital technologies to the emergence of new therapies, the life sciences industry has seen dramatic changes over the last decade. This continual evolution has created an environment that is more dynamic and nuanced than ever before, with opportunities and challenges presenting themselves every day.
With these changing trends in mind, it’s clear that there’s no going back to how things were before – and this is a good thing. Life sciences companies must be prepared to embrace new approaches while staying rooted in their mission of improving health outcomes worldwide. We can look forward to a brighter future with continued innovation and determination.
Invest in Cloud Concinnity to Improve The Clinical Trial Experience
The Cloud Concinnity platform was built to meet the specific needs of clinical trial managers, CROs, and DSMBs. Our cloud-based system provides trial stakeholders with a centralized platform for patient information, communications, processes, and reporting onto a single, secure platformhub to improve their quality of life.
To learn more, schedule your demo today.